Laboratory

Orchard Software Announces New Billing Functionality to Improve Reimbursements

Retrieved on: 
星期二, 四月 23, 2024
Financial management, Health, RCM, Patient satisfaction, Health care, Insurance, Orchard, Laboratory, LIS, Revenue cycle management, API

CARMEL, Ind., April 23, 2024 /PRNewswire/ -- Today, Orchard Software announced the release of its expanded billing functionality to include insurance verification automation.

Key Points: 
  • CARMEL, Ind., April 23, 2024 /PRNewswire/ -- Today, Orchard Software announced the release of its expanded billing functionality to include insurance verification automation.
  • Orchard's newly enabled insurance verification can decrease denial rates that may delay reimbursements.
  • "Healthcare organizations and their laboratories can benefit from our updated billing support by integration with insurance verification vendors, eliminating that manual process and allowing automated responses from insurance verification vendors to update the patient record," said Billie Whitehurst, CEO of Orchard Software.
  • This added support will reduce billing discrepancies and allow laboratories to seamlessly perform insurance verification prior to claim submission—reducing rejected claims and improving billing efficiency.

Copia Scientific Enters Agreement with Leading Pharmaceutical Company

Retrieved on: 
星期二, 四月 23, 2024
One Solution, Advantage Business Media, Science, Partnership, Laboratory

TAUNTON, Mass., April 23, 2024 /PRNewswire/ -- Copia Scientific, a provider of laboratory equipment and service solutions, is pleased to announce that it has entered into a strategic agreement with a top 10 global Fortune 50 pharmaceutical company.

Key Points: 
  • TAUNTON, Mass., April 23, 2024 /PRNewswire/ -- Copia Scientific, a provider of laboratory equipment and service solutions, is pleased to announce that it has entered into a strategic agreement with a top 10 global Fortune 50 pharmaceutical company.
  • This collaboration marks a significant milestone for Copia Scientific and underscores its commitment to advancing scientific research and development in the pharmaceutical industry.
  • The agreement includes the global distribution of Certified Pre-Owned Laboratory Equipment and Service in select international sites.
  • "We are thrilled to partner with one of the world's leading pharmaceutical companies," said Dyan Reagan, Chief Operations Officer at Copia Scientific.

J.S. Held Celebrates Scientific and Technical Experts on World Laboratory Day

Retrieved on: 
星期二, 四月 23, 2024
Librarian, Ceramic, Mechanics, Harvard University, Virtual reality, Laboratory, Explosion, Metal, Fire, Law enforcement, Johns Hopkins, Cognition, Accident, Forward, Research, Consultant, Ocean Tomo, Environment, Engineering, CFEI, Science, Semiconductor, Plastic, Perception, Pedestrian, Anomaly, Optometry

Held, proudly celebrating 50 transformative years, recognizes scientific and technical experts on World Laboratory Day.

Key Points: 
  • Held, proudly celebrating 50 transformative years, recognizes scientific and technical experts on World Laboratory Day.
  • Held, a global consulting firm, showcases its industry-leading laboratory capabilities and experts.
  • "On World Laboratory Day, we are proud to showcase these incredible experts and the laboratory support structure that plays a critical role in our mission to transform our clients' challenges into opportunities."
  • World Laboratory Day celebrates the importance of laboratories and the professionals who work in them.

/R E P E A T -- Power Nickel Releases Thick High-Grade Assays of Copper, PGMs, Gold and Silver from its new Lion Discovery/

Retrieved on: 
星期二, 四月 23, 2024
Project, QAQC, Laboratory, News, The Company, GeoVector, Calibration, Rb, Dry, Consultant, ICP-OES, Gold, CRM, Orientation, Lynch, Silver, Palladium

The Company's Winter 2024 drill program ended with 15 successful holes at the Lion Discovery.

Key Points: 
  • The Company's Winter 2024 drill program ended with 15 successful holes at the Lion Discovery.
  • Additional assays to be released when received shortly could evidence ongoing progress on the significant discovery that has been made (see Figure 1 below).
  • Power Nickel will continue to drill at the Lion Discovery in the upcoming summer season, following up PN-24-051 (this release) and PN-24-062, the deepest mineralized intersections to date.
  • QAQC and data validation was performed on these portions of the holes where assays are fully integrated, and no material error were observed.

Power Nickel Releases Thick High-Grade Assays of Copper, PGMs, Gold and Silver from its new Lion Discovery

Retrieved on: 
星期一, 四月 22, 2024
Project, QAQC, Laboratory, News, The Company, GeoVector, Calibration, Rb, Dry, Consultant, ICP-OES, Gold, CRM, Orientation, Lynch, Silver, Palladium

The Company's Winter 2024 drill program ended with 15 successful holes at the Lion Discovery.

Key Points: 
  • The Company's Winter 2024 drill program ended with 15 successful holes at the Lion Discovery.
  • Additional assays to be released when received shortly could evidence ongoing progress on the significant discovery that has been made (see Figure 1 below).
  • Power Nickel will continue to drill at the Lion Discovery in the upcoming summer season, following up PN-24-051 (this release) and PN-24-062, the deepest mineralized intersections to date.
  • Kenneth Williamson, Géo, M.Sc., VP Exploration at Power Nickel, is the qualified person who has reviewed and approved the technical disclosure contained in this news release.

Two Herbalife Laboratories Earn My Green Lab Certification Bringing the Total Labs Certified to Six

Retrieved on: 
星期一, 四月 22, 2024
United Nations, Herbalife, Lab, Laboratory, Safety, Certification, Sustainability, Health, Research, Carbon footprint, Water, Development, United, Science, Sensory, Quality control, Organization

LOS ANGELES, April 22, 2024 /PRNewswire/ -- Herbalife, a premier health and wellness company, announced today that two more of its laboratories have completed the My Green Lab Certification Program, at the 'Green' level, signifying the highest level of certification in the program. These accomplishments demonstrate the company's continuous progress towards its sustainability goals of reducing its carbon footprint and attaining Green-level certifications for all of its laboratories by the end of 2030, as outlined in its 2021-2022 Global Sustainability Report. The two labs that received the most recent certification were the Center of Excellence Analytical Laboratory in Bangalore, India and the Quality Laboratory at the Herbalife Innovation Manufacturing Facility in Winston-Salem North Carolina (HIMWS). Out of the company's 19 laboratories around the world, to date, six have received the prestigious 'Green'-level certification and five more are targeting certification before the end of the year.

Key Points: 
  • To achieve the Green level, qualifying laboratories must meet 80 percent or more of the Green Lab assessment actions implemented during the program.
  • Herbalife partnered with My Green Lab in 2021 to develop more eco-efficient operations for its eight Quality Control laboratories around the world.
  • Since starting the program, three more of the Company's R&D and testing laboratories also joined the My Green Lab Certification program.
  • Herbalife's Sensory and Food Laboratory in Torrance, California was the fourth Herbalife lab to earn a Green-level certification in September 2023.

Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns

Retrieved on: 
星期一, 四月 22, 2024
HPS, Safety, LNP, Waters Corporation, Vaccine, Particle size, Therapy, HPLC, Patient, Laboratory, Messenger, WAT

MILFORD, Mass., April 22, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today introduced new GTxResolve Premier Size Exclusion Chromatography (SEC) 1000Å 3-micron (3 µm) Columns. Waters has implemented a unique combination of novel packing materials and MaxPeak™ Premier High-Performance Surface (HPS) technology into the columns to help scientists accelerate the development of gene-based therapeutics, including cell & gene, mRNA and LNPs.

Key Points: 
  • New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene-based therapeutics.
  • MILFORD, Mass., April 22, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today introduced new GTxResolve Premier Size Exclusion Chromatography (SEC) 1000Å 3-micron (3 µm) Columns.
  • Waters GTxResolve Premier SEC Columns support the growing demand for mRNA, LNP, and viral-vector-based therapies.
  • GTxResolve Premier SEC Columns are engineered to reduce problematic non-specific binding, minimize mobile phase method development challenges, and provide higher throughput separation efficiency.

Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns

Retrieved on: 
星期一, 四月 22, 2024
HPS, Safety, LNP, Waters Corporation, Vaccine, Particle size, Therapy, HPLC, Patient, Laboratory, Messenger, WAT

MILFORD, Mass., April 22, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today introduced new GTxResolve Premier Size Exclusion Chromatography (SEC) 1000Å 3-micron (3 µm) Columns. Waters has implemented a unique combination of novel packing materials and MaxPeak™ Premier High-Performance Surface (HPS) technology into the columns to help scientists accelerate the development of gene-based therapeutics, including cell & gene, mRNA and LNPs.

Key Points: 
  • New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene-based therapeutics.
  • MILFORD, Mass., April 22, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today introduced new GTxResolve Premier Size Exclusion Chromatography (SEC) 1000Å 3-micron (3 µm) Columns.
  • Waters GTxResolve Premier SEC 1000Å 3 µm Columns address those challenges by providing higher sensitivity, resolution, and throughput by combining novel particle technology with low adsorption MaxPeak Premier HPS Technology.
  • GTxResolve Premier SEC Columns are engineered to reduce problematic non-specific binding, minimize mobile phase method development challenges, and provide higher throughput separation efficiency.

Ibex Medical Analytics Wins Edison Bronze Award for AI-Powered Breast Cancer Diagnostics Solution

Retrieved on: 
星期五, 四月 19, 2024
Protein, Cell, Laboratory, Breast, HER2, Woman, Hospital, AI, Breast cancer, TILS, Immunohistochemistry, IHC, Knowledge, Oncology, Entrepreneurship, LVI, Ibex, Marie Cassidy, Patient, Edison Awards, Neoplasm, Diagnosis, Medical imaging

BOSTON, April 19, 2024 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced that Galen™ Breast HER2 has been named a bronze winner of the 2024 Edison Awards in the Diagnostic Technologies category. The awards, named after inventor Thomas Alva Edison, honor companies and innovations that are shaping the future, creating a positive impact in the world and improving lives.

Key Points: 
  • BOSTON, April 19, 2024 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced that Galen™ Breast HER2 has been named a bronze winner of the 2024 Edison Awards in the Diagnostic Technologies category.
  • Breast cancer impacts one in eight American women and as such, accurate and timely diagnosis is key to guiding treatment decisions and improving survival rates.
  • Ibex's Galen Breast HER2 is an AI-powered scoring solution that helps pathologists assess HER2 expression in tumors to support identification of breast cancer patients eligible for targeted therapies.
  • The award highlights our innovative approach in developing AI-powered tools such as Galen Breast HER2 that set the new standard in breast cancer diagnosis."

Texas Biomed researching vaccines and treatments for highly pathogenic avian influenza

Retrieved on: 
星期四, 四月 18, 2024
Poultry, Laboratory, Cattle, Chicken, Risk, SARS-CoV-2, Mammal, CDC, Infection, Texas Biomedical Research Institute, Research, Vaccine, Cat, Virus, Multimedia, Mink, Dog, Antibody, SAN, COVID-19, Fatality, Goat, Fox

SAN ANTONIO, April 18, 2024 /PRNewswire/ -- Researchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains that closely mirror the one recently detected in cows, chickens and one person in Texas.

Key Points: 
  • SAN ANTONIO, April 18, 2024 /PRNewswire/ -- Researchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains that closely mirror the one recently detected in cows, chickens and one person in Texas.
  • Texas Biomed has a team of virologists and immunologists with experience studying highly pathogenic avian influenza.
  • Texas Biomed has a team of virologists and immunologists with deep experience studying influenza viruses and very recently expanded its research scope to include highly pathogenic avian influenza.
  • Dr. Elsayed has been studying avian influenza for 16 years and joined Texas Biomed in 2023.